The advent of medications targeting insulin resistance, such as tirzepatide, offers new potential avenues for treatment that may influence hair regrowth
its use should be evaluated in patients with an estimated GFR of 30 to 44 mL per minute per 1.73 m 2
And part of the reason that the confusion has become that, you know, originally, I would say maybe 6 to 8 months ago when there was a shortage of these medications out there, there was a lot of discussion about, well, how can we deprive people with diabetes, these medications to give it to people who dont have diabetes and just want to lose weight with the shortage
But the data on long-term semaglutide use makes clear that the medication is whats maintaining the solution
Like Ipamorelin, it interacts with the GHS-R1a receptor , making it a valuable compound for research involving endocrine regulation and peptide pharmacology